Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -4.90% | 58.57 | 0.0% | $919.92m | |
| AMGN | Amgen, Inc. | 1.22% | 258.24 | 1.3% | $759.50m | |
| GILD | Gilead Sciences, Inc. | 0.38% | 76.35 | 1.0% | $735.36m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.18% | 622.45 | 2.5% | $672.88m | |
| NVAX | Novavax, Inc. | 2.43% | 81.64 | 102.0% | $616.96m | |
| BIIB | Biogen, Inc. | 0.13% | 265.12 | 1.6% | $544.40m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.68% | 291.10 | 1.9% | $526.40m | |
| ILMN | Illumina, Inc. | 1.24% | 373.10 | 3.5% | $309.63m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.08% | 112.30 | 2.0% | $225.16m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.75% | 126.78 | 4.3% | $216.16m | |
| SGEN | Seattle Genetics, Inc. | 0.90% | 169.03 | 6.1% | $202.76m | |
| SRNE | Sorrento Therapeutics, Inc. | -1.15% | 6.85 | 1.8% | $187.20m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.77% | 162.75 | 13.9% | $164.07m | |
| INCY | Incyte Corp. | 3.72% | 106.47 | 2.5% | $163.74m | |
| IMMU | Immunomedics, Inc. | 1.71% | 37.54 | 13.3% | $157.98m |
Company Profile
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.